A subscription to JoVE is required to view this content. Sign in or start your free trial.
The present protocol describes an experimental model based on ink-staining which can be used for in vitro implant surface decontamination and roughness research to contribute to clinical decision-making.
Various mechanical methods have been proposed for decontaminating dental implant surfaces with varying success. This in vitro study evaluated the decontamination efficiency of an air abrasion (AA) system with erythritol powder, a polyether-ether-ketone (PEEK) ultrasonic tip, and titanium curettes (TIT) and their effects on implant surface topography using scanning electron microscopy (SEM). A total of 60 implants were stained with permanent red ink and placed in 3D-printed Class 1A and Class 1B peri-implantitis defects, forming six groups (n=10 per group) based on defect type and treatment protocol. Additionally, one positive and one negative control implant was used. Erythritol powder, PEEK ultrasonic tips, and titanium curettes were applied for 2 min in Class 1A defects and 3 minutes in Class 1B defects. Residual red ink areas were quantified with digital software, and implant surface changes were analyzed using SEM and EDS. None of the methods achieved complete decontamination. However, erythritol powder was significantly the most effective, leaving a residual ink rate of 24% ± 6% (p < 0.001). PEEK ultrasonic tips resulted in 41% ± 4% residual ink, while titanium curettes left 55% ± 3%. Significant differences were observed among all methods. No significant difference in decontamination efficacy was found between Class 1A and Class 1B defects. SEM analysis showed minimal surface damage with erythritol powder and PEEK tips, whereas titanium curettes caused moderate to severe damage. Based on both decontamination efficiency and surface preservation, erythritol powder and PEEK tips are safe and effective options for peri-implantitis treatment, while titanium curettes are less effective and cause considerable surface damage. These findings may assist clinicians in peri-implantitis treatment planning.
Dental implant treatment is the most common and preferred protocol for replacing missing teeth worldwide. Long-term follow-up studies have shown that the use of implant-supported restorations in the treatment of complete or partial edentulism provides predictable results and high success rates in terms of survival. However, various complications affecting the hard and soft tissues may arise following the surgical placement and restoration of implants1. In 2017, the World Workshop on the Classification of Periodontal and Peri-implant Diseases and Conditions introduced definitions and differential diagnoses for diseases affecting peri-implant tissues2. According to this definition, peri-implantitis is an irreversible pathological condition characterized by clinical signs of inflammation, including bleeding on probing and/or suppuration, increased probing depths, and/or recession of the mucosal margin in the peri-implant mucosa, and radiographic loss of supporting bone2. The etiology of peri-implant diseases is multifactorial, and some individuals are more susceptible to this condition than others. Specific predispositions of individuals may increase the risk of peri-implant disease development, which may lead to implant loss. Other factors that play a role in the etiology of peri-implant diseases are patient-related factors (smoking, systemic diseases, periodontal disease history, oral hygiene); the condition of the keratinized mucosa, quantity and quality of bone and soft tissues at the implant site; forces on the implant and surrounding tissues; complications encountered during implant placement; and the experience and skill of the physician performing surgical and prosthetic treatments2. In addition, a new risk assessment and treatment concept has recently been introduced, the Implant Disease Risk Assessment Tool (IDRA)3. This tool was developed as a functional diagram consisting of eight parameters, each with a documented association with peri-implantitis. The vectors of the octagon are the history of periodontitis, percentage of implant and tooth sites with bleeding on probing (BoP), number of teeth/implants with probing pocket depths ≥ 5 mm, rate of periodontal bone loss (radiographs in relation to a patient's age), susceptibility to periodontitis, frequency of supportive periodontal therapy (SPT), and design of the prosthesis.
Recent systematic reviews have shown that the prevalence of peri-implantitis is 19.53% at the patient level and 12.53% at the implant level3. Regarding approximately more than 5 million implants being placed each year worldwide, with a market size of more than 4 billion USD, peri-implantitis represents a major health problem for the population. If left untreated, peri-implantitis results in the loss of the affected implant and the implant-supported prosthesis, causing a big distress for both the dentist and the patient.
The treatment of peri-implant diseases can be divided into non-surgical and surgical approaches. Although there is a reasonable expectation for the success of endpoints in the treatment of periodontitis4, comparable evidence for the treatment of peri-implantitis is still scarce. Therefore, the rationale for a staged approach and non-surgical therapy of peri-implantitis is to attempt biofilm and inflammation control with relatively simple approaches before increasing treatment invasiveness and to perform the surgical step when better biofilm and risk factor control is achieved. This includes OH instructions and motivation, risk factor control, control of biofilm-retaining factors, and prosthesis cleaning/removal/modification, including assessment of prosthesis components, supramarginal and sub-marginal instrumentation, and concomitant periodontal treatment when needed. Thus, non-surgical therapy should always be the first step5. For early peri-implantitis, reducing risk factors and non-surgical treatment may suffice, but complete biofilm removal in deep pockets after bone loss is often challenging. During the reevaluation phase after non-surgical treatment, persistent pocket depths (≥ 6 mm) and bleeding on probing (BoP) indicate potential progression of peri-implantitis. If these signs are present, surgical interventions are recommended6. The surgical therapy of peri-implantitis includes (i) open flap debridement, (ii) resective flap surgery, (iii) the management of peri-implant osseous defects using reconstructive approaches, (iv) additional methods for implant surface decontamination and (v) adjunctive use of local/systemic antibiotics7.
The major etiological factor of peri-implantitis is the pathogenic biofilm colonized on the implant surface6. Removing this biofilm is the main principle and goal of all treatment protocols, which involve mechanical, chemical, and laser decontamination methods7.
Mechanical debridement employs plastic, carbon, and titanium curettes, ultrasonic devices with plastic and metal tips, titanium brushes, and air-abrasive (AA) systems with various powders. Although complete elimination of the biofilm is difficult to achieve, these therapies provide clinical benefits. Various clinical interventions, including mechanical debridement protocols with or without antiseptics8, antibiotics9, as well as resective and regenerative surgery10, have been used with varying degrees of clinical success. However, they also induce changes in the chemical and physical properties of the implant surface, possibly complicating new bone formation and re-osseointegration.
Among mechanical methods, AA procedures using different powder compositions have shown the best cleaning efficacy11,12,13. However, the presence of residual particles can alter surface topography and reduce biocompatibility14. Glycine, followed by sodium bicarbonate, is the most used powder in AA systems8. Recently, smaller air-abrasive particles like erythritol (14 µm) have gained interest for effective decontamination with reduced surface damage9. Titanium and plastic curettes, which cause less surface damage than steel tips, are effective in biofilm decontamination15. Ultrasonic scaler tips made from poly-ether-ether-ketone (PEEK) also reduce bacterial load with minimal surface damage10. Decontamination methods must consider the high roughness of implant surfaces and aim to remove bacterial biofilm without causing significant surface damage. Although extensive in vitro, in vivo, and clinical research has been performed, there is still no consensus and a gold standard protocol for peri-implantitis treatment to date. The increasing prevalence of peri-implant diseases due to numerous dental implants necessitates an evidence-based, predictable approach to treating contaminated surfaces. This study aims to evaluate the effectiveness of different decontamination methods -air abrasive (AA) systems, PEEK ultrasonic tips, and titanium curettes-on implant surface decontamination and to assess their impact on implant surface roughness by SEM analysis.
The study protocol was approved by the ethical committee (TBAEK-363) of Akdeniz University, Antalya, Turkey. This study was supported by the Akdeniz University Research Fund (Project number: TDH-2024-6676). The study utilized a screw-shaped dental implant (PrimeTaper EV Implant) with dimensions of 4.2 mm x 11 mm, featuring a micro-thread design measuring 1.7 mm on the collar. Surface preparation with sandblasting and acid-etching with diluted hydrofluoric acid to achieve the well-defined OsseoSpeed surface.
1. Preparation of experimental peri-implantitis models
NOTE: Three decontamination mechanical treatment methods (air abrasive (AA), polyetheretherketone (PEEK) ultrasonic, and titanium curettes; Table of Materials) in two different peri-implantitis defect types11 (Class 1A and Class 1B) were analyzed. Thus, there were six experimental groups (Figure 1). A total of 62 implants were used, including one positive and one negative control implant. This in vitro study design, initially developed by Sharhmann et al.16, has been modified by various researchers12,13,14,15,16,17,18 in the literature (Figure 2). Assuming a 10% difference in biofilm removal efficacy between groups, the sample size was determined as 60 (10 for each group) for six groups with G*power, an effect size of 0.50, a type I error of 5%, and 80% power.
Figure 1: Flowchart of experimental groups. Please click here to view a larger version of this figure.
2. Staining of implants
3. Placement of stained implants
4. Decontamination of implants
5. Photographic imaging
6. Image analysis
7. SEM analysis
Figure 2: Flowchart of the study. Please click here to view a larger version of this figure.
8. Statistical analysis
The experimental protocol described here for analyzing the decontamination of implant surfaces revealed significant differences among various treatment procedures. In addition, the post-treatment SEM protocol also showed significant changes on the implant surfaces with varying degrees among study groups.
Implant-level comparisons (Total implant means) after decontamination
Implant-level comparisons were carried out by comparing the general means of each implant (the meas...
The methodology of in vitro surface analysis of dental implants affected by peri-implant disease has always been challenging due to the inflammatory and bacterial nature of the pathogenic mechanisms occurring on the rough surfaces of the implant. Several concerns include the sample material choice, mimicking biofilm on the surface, choosing the peri-implantitis defect type, representing clinical conditions during the in vitro procedures, variations of the decontamination procedures, and the methods of determinin...
The authors have no conflicts of interest to disclose.
The implants used in the study were supported by Dentsply Sirona.
Name | Company | Catalog Number | Comments |
3D Printer | DentaFab, Istanbul, Turkey | To produce experimental periimplantitis defects | |
3D Printing Resin | Alias, Istanbul,Turkey | To produce experimental periimplantitis models | |
3D Scanner | DOF Inc. EDGE, Seoul ,Republic of Korea | Used to scan the dental phantom model | |
Air Abrasive system | AIRFLOW Plus PowderE.M.S., Electro Medical Systems S.A., Nyon, Switzerland | Used to decontaminate implant surface | |
CAD/CAM Software | Exocad 3.2 Elefsina | To produce experimental periimplantitis defects | |
Camera | Canon EOS 70D, Japan | In order to obtain photographic records of implants | |
Dental implant | DS PrimeTaper, Dentsply Sirona, Hanau, Germany | ||
Light-Curing Unit | Solidilite V, Japan | Used to curing experimental models in laboratory | |
Permanent ink | Edding, Germany | Used to stain the implant surface for mimicking biofilm | |
Physiodispenser | Dentsply Sirona, Hanau, Germany | To place the implants in the experimental models | |
SEM Device | FEI QUANTA FEG 250 FEI Technologies Inc. (Oregon, United States | Used to analyze topograhic changes on the implant surface | |
Surgical implant set | Dentsply Sirona, Hanau, Germany | To place the implants in the experimental models | |
Titanium Currette | Langer ½ Titanium Currette, Hu-Friedy, Chicago, IL, USA | Used to decontaminate implant surface | |
Ultrasonic PEEK Tip | PI-MAX Implant Scaler, E.M.S., Electro Medical Systems S.A., Nyon, Switzerland | Used to decontaminate implant surface |
Request permission to reuse the text or figures of this JoVE article
Request PermissionExplore More Articles
This article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved